Green light for cancer drugs developed by AI specialist Owkin
AI company has its breast cancer and colorectal therapies approved for use in Europe
Read More
Author: John Pinching
Avacta announces clinical study of AVA6000
Pro-doxorubicin will advance to the fourth dose following a positive review of safety and tolerability
Read More
Manus Bio receives additional funding to combat malaria
Fourth award from the Bill & Melinda Gates Foundation will support artemisinin research
Read More
Kaiku Health enters wider partnership with Novartis
Following a successful collaboration, the companies will now partner to focus on precision medicine
Read More
Psyomics links up with Hertfordshire Partnership University NHS Foundation Trust
Hertfordshire Trust to invest in mental health care with wide-ranging digital assessment platform
Read More- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
